Americas

The stock of Chinese biopharmaceutical company BeiGene has shot up 18% on its first day of trading on the Nasdaq.

Investors have been looking for ways to explain the poor performance of global banks this year. While negative interest rates in Europe and Japan have gained the attention of some, others are focused on bank exposure to the energy sector to explain low equity valuations.

Barclays will offload a legacy derivatives portfolio to JP Morgan as part of the British bank's plans to run down its non-core assets.

Tradeweb Markets has launched an electronic over-the-counter marketplace for US-listed exchange traded funds.

Medium term note investors believe the Mexican peso may be undervalued, as they took punts with a series of deals in the currency.

Steelmaker Companhia Siderurgica Nacional (CSN) could be the next major Brazilian corporate to be forced into a debt restructuring, Fitch Ratings has warned.

Chinese biopharmaceutical company BeiGene has raised $158m from a Nasdaq IPO after increasing the size of the offer and pricing it at the top of guidance.

January trading produced one of the most volatile starts to a year on record, with volumes in listed options and futures reflecting heightened activity.

Acadia, the US psychiatric and behavioural healthcare provider, closed its $955m term loan facility on Thursday after first adding, then removing, a sterling tranche.

SolarWinds, the US IT management software firm, priced its $1.5bn first lien acquisition debt package at a hefty discount on Monday while finalising the euro tranche size.

Argentina’s government reopened negotiations with holdout creditors on Monday after securing a $5bn loan from seven global banks last week.

Chinese drug maker BeiGene has decided to price its US listing on Tuesday evening, a day earlier than planned, according to sources close to the deal.